Chronic myeloid leukemia: a type of MPN
- PMID: 35620905
- PMCID: PMC9242828
- DOI: 10.5045/br.2022.2021173
Chronic myeloid leukemia: a type of MPN
Abstract
This review article classifies chronic myeloid leukemia (CML) based on cytogenetic analyses and different mutations detected in CML patients. The use of advanced technologies, such as karyotyping, fluorescent in situ hybridization, and comparative genomic hybridization, has allowed us to study CML in detail and observe the different biochemical changes that occur in different CML types. This review also highlights the different types of receptor and signaling pathway mutations that occur in CML.
Keywords: Chronic myeloid leukemia; Cytogenetics; Myeloproliferative neoplasms; Philadelphia chromosome.
Conflict of interest statement
No potential conflicts of interest relevant to this article were reported.
Figures
Similar articles
-
Recurrent Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Chronic Myeloid Leukemia.Methods Mol Biol. 2017;1541:247-256. doi: 10.1007/978-1-4939-6703-2_20. Methods Mol Biol. 2017. PMID: 27910028 Review.
-
Chronic myeloid leukemia: Relevance of cytogenetic and molecular assays.Crit Rev Oncol Hematol. 2016 Jan;97:263-74. doi: 10.1016/j.critrevonc.2015.08.020. Epub 2015 Aug 29. Crit Rev Oncol Hematol. 2016. PMID: 26412717 Review.
-
Cytogenetics of the chronic myeloid leukemia-derived cell line K562: karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization.Cancer Genet Cytogenet. 2000 Apr 1;118(1):1-8. doi: 10.1016/s0165-4608(99)00169-7. Cancer Genet Cytogenet. 2000. PMID: 10731582
-
Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.Cancer Genet Cytogenet. 1999 Jan 1;108(1):6-12. doi: 10.1016/s0165-4608(98)00120-4. Cancer Genet Cytogenet. 1999. PMID: 9973917
-
Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.Acta Biomed. 2018 Apr 3;89(3-S):38-44. doi: 10.23750/abm.v89i3-S.7219. Acta Biomed. 2018. PMID: 29633732 Free PMC article.
Cited by
-
BCR::ABL1-induced mitochondrial morphological alterations as a potential clinical biomarker in chronic myeloid leukemia.Cancer Sci. 2025 Mar;116(3):673-689. doi: 10.1111/cas.16424. Epub 2024 Dec 9. Cancer Sci. 2025. PMID: 39652455 Free PMC article.
-
Expression profiles of miR-411 and SPRY4 as indicators of disease progression and treatment in chronic myelogenous leukemia.Sci Rep. 2025 Aug 20;15(1):30647. doi: 10.1038/s41598-025-13100-5. Sci Rep. 2025. PMID: 40835851 Free PMC article.
-
Artificial intelligence-driven label-free detection of chronic myeloid leukemia cells using ghost cytometry.Sci Rep. 2025 Jul 1;15(1):21046. doi: 10.1038/s41598-025-06664-9. Sci Rep. 2025. PMID: 40594492 Free PMC article.
References
-
- Besa EC, Grethlein SJ. Chronic myelogenous leukemia (CML): practice essentials, background, pathophysiology. Medscape; New York, NY: 2021. [Accessed September 11, 2021]. at https://medicine.medscape.com/article/199425-overview .
-
- Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. IARC Press; Lyon, France: 2008. - DOI
Publication types
LinkOut - more resources
Full Text Sources